Full video transcriptClick to expand
Auto-generated transcript of @bigtwig_1's video. Quoted here for educational fact-check commentary; original creator retains all rights to the video content.
- 0:00Hey guys, I get a lot of questions about BPC and TB-500.
- 0:04What are they? How do they work? How do I inject it? Where do I inject it?
- 0:07How much do I inject? What about the frequency? So I'm going to cover those questions for you today.
- 0:11Now we do have these peptides and other forms. We have a nasal form, we have an oral form,
- 0:16we do have the peptides in a topical form. We have them standalone, so BPC-157 independent by itself.
- 0:23And we also have TB-500 independent by itself. We also have them as a combination. I'm firm believer
- 0:28that in my own practice and application with using these two peptides and pairing them together,
- 0:33I've seen significant results as far as improving with health. When it comes to healing, when it comes
- 0:38to inflammation control, pain control, there's tremendous benefits within these two peptides.
- 0:44So the first thing you're going to do is you're going to need to have some bacteriostatic water,
- 0:47or backwater. You can get reconstitution solution. I use backwater. I get this right on explicitsarms.com.
- 0:54From there, we're going to take our fresh vial of the BPC-157 and TB-500. Now you'll notice it's a
- 1:005 milligram vial. What does that mean? That means it's 5 milligrams of each active ingredient. What
- 1:06we're going to do is we're going to pop the top off. Okay, top is off. We're going to have to
- 1:11constitute it and put this bacteriostatic water inside of this vial. These are always going to
- 1:15be sterile syringes. So what we're going to do is we're going to pull this to 100 units. Now we
- 1:20don't always have to do this, but I like to do this. It just helps me put a little air in this.
- 1:24It gets a little more pressure there. When you pull it out, it helps put the liquid in here. So we're
- 1:27going to put it in in the middle here. Okay, we'll push the air in there. Look, without me even pulling,
- 1:34it's pulling it out organically. I'm going to finish doing the job for it and pull this bad
- 1:40way out organically. We're going to pull it down to 100 units. Now when you're getting these
- 1:47syringes, okay, we're at 100 units. You're always going to want to get the 1 milliliter or 100 unit
- 1:53syringe. 100 units. These are 1 milliliter or 1cc syringes. So we're going to put 100 units,
- 1:58AKA 100 units or 1 milliliter or 1cc of water into this. Now when you see this, you'll see a
- 2:03little valley in the middle. Now again, these are sterile. Just pop the tops off. So I don't have to
- 2:08use the alcohol swabs to sterilize them because they're already sterile. After I do this, and once I
- 2:12store it, which when you're done doing this, you always want to store it in a refrigerator. Then I
- 2:16will need to swab it again before I pull the compound out with a new needle. I always use a new
- 2:22needle. You're going to lose the sharp of the tip and you don't want to cross contaminate any kind
- 2:25of bacteria because what could happen if there's bacteria dormant on there, you can push that
- 2:29bacteria in here. It's going to grow in that liquid and you don't want that to happen. So it'll
- 2:34ruin everything. Right now, sterile, we're going to put this in here. You can see the valley and
- 2:39we're going to do it at an angle. I like to put the water against the glass first. This is a very
- 2:44fragile compound. All these peptides are fragile compounds. Okay, so when we do that,
- 2:50now the first thing you're going to do is cap your needle. I've been stuck one too many times
- 2:55by myself. When you put the cap on, go slow. You're going to discard this needle. So now what do you
- 3:00do with this? Because you have a powder that has to be constituted. You don't want to shake it.
- 3:04It's a slow roll. Slowly roll this thing. Also notice my fingers are not on top. It's just on the sides
- 3:10so that I'm not getting bacteria on the rubber where I'm then going to have bacteria
- 3:13contaminate the actual compounds inside the vial. Now it's finally dissipated. The next question is
- 3:19dosing. How do I dose it? If we don't have these two compounds together, what you're going to want
- 3:23to do for dosing, generally it's going to be 2 milligrams or 2.5 milligrams of the TB-500 administered
- 3:29two times per week. And the BPC anywhere from 250 micrograms daily up to 500 micrograms daily
- 3:35or every other day. Because we have a combination of the two peptides, 5 milligrams of each, it makes
- 3:40the most sense. And I've actually noticed more benefit from microdosing the TB-500 more frequently
- 3:46at 500 micrograms every other day. You don't want to pin daily at the 250 micrograms. For dosing,
- 3:52what we're looking at is either 250 micrograms of each compound daily or 500 micrograms of each
- 3:58compound every other day. That means that a vial like this is going to last you 20 days. Regardless
- 4:03of how you dose it, whether it's 250 every day or 500 micrograms over the day, it's going to last
- 4:07you 20 days. But Tim, how do we get to 500 micrograms? Great question. I'm going to walk you through
- 4:12the process. Let's do some simple math. If this whole vial is 1cc of backwater or 100 units, so
- 4:19remember, 1cc equates 100 units. And if this whole vial is 100 units, and we put that in there, and that's
- 4:265 milligrams of each compound and a milligrams equal to 1000 micrograms, you can also go to
- 4:33Google and just type this in. There's like a peptide calculator, but we'll do it old-fashioned. We're
- 4:36gonna get out our handy dandy calculator. What we're going to do is 5000 micrograms, 5000, and we're
- 4:42going to divide that by 100. And that means every one unit is 50 micrograms. What does that mean?
- 4:49Well, 50,000, 100,000. Oh wait, that means 10 units is going to be 500 micrograms. It's like magic.
- 4:55Call me Harry Houdini right there guys. 10 units. 10 I use is 500 micrograms. If you don't have a
- 5:03huge injury, let's say you have a couple different injuries, I would always recommend subcutaneous,
- 5:06which I'm going to demonstrate to you how to do here in a second. But if you do have an acute
- 5:10injury, this is where going directly into that area, the effect that are injured area is would
- 5:14be beneficial. As long as you have good muscle tissue there or fat tissue there, if it's a joint,
- 5:19like your wrist or ankle or something like that, I would recommend going into the stomach fat
- 5:23subcutaneous injection. We're going to pretend that this has been used before, even though it
- 5:27hasn't, and we're going to sanitize this. Now that's nice and clean. The next thing we're going to do
- 5:32is sanitize our injection site, which is going to be my belly. That way, no bacteria can get in there,
- 5:36we're not leaving any room for any infection or things of that nature. Okay, now remember guys,
- 5:41our unit of measurements. If we're doing 500 micrograms of each, that means 10 units. We find that
- 5:46little valley in the middle, see a little valley there. We're going to put our needle right in there.
- 5:51It's a range. We're going to pull out, and this is what I didn't pressurize the syringe.
- 5:55This is why it's important to pressurize it so you're not sitting here literally watching it drip out.
- 5:59It just takes an extra 10-15 seconds. So now that we got the 10 units, we're going to pull up,
- 6:05holding our finger like that the whole time, not allowing that vacuum to pull the liquid back
- 6:11into the vial. So now we're going to inject this into the belly. Guys, it's a tiny little pinch.
- 6:16It does not hurt. You want to go about an inch, sorry, my beard's in the way. You want to go about
- 6:21an inch away from your belly button. You're going to pinch this skin just like this. You're going to
- 6:24go about an inch away from your belly button. Slowly put it in. Okay, once it's in there,
- 6:36you're just going to push the liquid in. Okay, once it's all in, we're going to slowly pull it out.
- 6:45You're going to take that same sanitary pad, alcohol pad, or whatever you have for alcohol
- 6:49to clean. You're going to wipe it. It's that simple. Remember, cap it and discard it. Now,
- 6:56the frequency, like I said, is going to be either daily or every other day. If you're going to do 500
- 7:00micrograms, you can do every... Guys, you can do 500 micrograms a year just going to run through it
- 7:04faster. In the research and studies that I found, there's no need to do more than either 250 micrograms
- 7:10daily or 500 micrograms every other day. As far as the length, the duration of time. How long are you
- 7:15supposed to take this BPC-157 and TB 504? Six weeks, eight weeks if necessary, four weeks if it's
- 7:21healed by then. I would say anywhere between four and six weeks, if you have to maybe do an extra
- 7:25two weeks you can, but there's really no need to go longer than eight weeks. Does it actually work?
- 7:28Yes, we have customers that I'm not going to release their names for confidentiality reasons.
- 7:32We have an elderly couple who is on a subscription plan from explicitsarms.com and they are on literally
- 7:38this exact compounds right here, this exact vial. It's a TB-500, BPC-157. The gentleman,
- 7:44he is I believe 70 in his early 70s. Both of his rotator cups are completely torn. There's no
- 7:49connective tissue in between. And apparently his wife has explained to me that he's very hard
- 7:54headed and stubborn. So he went to two or three different doctors, got MRI has done imaging and
- 7:58they said that no, he needs to get surgery done. Being old and stubborn and hard headed and he
- 8:02said I'm not doing that, I will heal myself and where he landed on explicitsarms.com. After two
- 8:07and a half months of taking that, his wife had some sort of a cancer in a granular area and she
- 8:12was left with kiloids scarring tissue, the granular area. She was on the exact same thing. After one
- 8:17month of her using this and two and a half months of him using it, within one month her scars
- 8:22are completely gone and doctors cannot believe it. Within two and a half months there was tissue,
- 8:26connective tissue ligaments that were rebinding and rebinding to themselves before he couldn't
- 8:31with his arms past here. Now he can live his arms almost over his head. The proof is right here in
- 8:36the peptides. You don't have to listen to me. I'm not trying to sell you something. I'm just
- 8:39showing you what has worked for me and worked for hundreds and hundreds of our customers. We see it
- 8:43on a daily base on a retail store. We see it on a daily base on our online stores and it truly is
- 8:48amazing. If there's a miracle, I can't call it something because it's not there's a miracle potion
- 8:52out there. It would be this. That's the in and out of the TB-500 and the BPC-157. If you have questions
- 8:58further than that, let me know. If you don't know how to do other stuff, let's just say like CGC
- 9:02DAC or CGC 157. No DAC. Again, guys, it's simple math. Use simple math. Use a calculator. Go to,
- 9:08I think there's like a peptide calculator.com. If I want to throw in 200 micrograms or 500
- 9:12micrograms of CJC daily, you just take the total amount, which is 5000 micrograms, regardless of
- 9:17how much liquid is in here. It's always going to be 5000 micrograms. And then you just do some simple
- 9:23division. So let's just say I put a CC of back to your static water in here. If I want to do 500
- 9:28micrograms, I'm going to do what? I'm going to pull to that 10 mark. Let's say I put two CCs
- 9:32in there for whatever reason. I'm going to do what? Well, to that 20 mark because 20 is now going to
- 9:36equate 500. So if there's questions beyond this that you do have, please reach out. We have a phone
- 9:41number. We have a website you can reach us at a retail location at Edgivinday. We're here
- 9:46seven days a week. Until next time, this is Big, Big Tim signing off explicitstorms.com.
@bigtwig_1's peptide therapy claims need serious scrutiny
Quick answer
BPC-157 and TB-500 are research peptides with preclinical data supporting healing and anti-inflammatory mechanisms, but neither has completed peer-reviewed human clinical trials establishing safety or efficacy for the indications described in this video. The creator provides a specific dosing protocol (250-500 mcg of each peptide daily or every other day) and sourcing guidance to a commercial SARMs vendor, neither of which is supported by clinical evidence or compliant with FDA regulations governing human peptide use. Any consideration of these compounds should occur under supervision of a licensed clinician with access to pharmacy-grade compounded preparations.
Video review standard
Clinical fact-check snapshot
FormBlends treats social health videos as a starting point, then checks the claim against medical context, source quality, safety limits, and whether licensed provider review belongs in the next step.
Evidence signal
Source-backed review
Regulatory reality
Access rules depend on the compound and patient situation
Safety screen
Viral claims can miss contraindications, dose escalation, medication interactions, and quality-control risks.
This page currently connects to 8 source-backed evidence items through visible references or structured citation data.
PubMed evidence trail
Research sources used to frame this page
For @bigtwig_1's peptide therapy claims need serious scrutiny, FormBlends checks the page topic against primary trials, systematic reviews, guidelines, and current PubMed-indexed literature where available. These citations are context, not medical advice, proof of eligibility, or a claim that every study applies to every patient.
Multifunctionality and Possible Medical Application of the BPC 157 Peptide
Used to frame BPC-157 as an investigational peptide with mixed preclinical and limited human evidence.
PubMed
Gastric pentadecapeptide BPC 157 and its role in accelerating musculoskeletal soft tissue healing
Supports cautious tissue-repair context without presenting BPC-157 as an approved therapy.
PubMed
beta-Thymosins
Background source for thymosin biology and tissue-repair mechanisms.
PubMed
Thymosin beta 4 and the eye: the journey from bench to bedside
Shows how thymosin beta-4 evidence differs by route, tissue, and clinical application.
PubMed
Provider decision path
Use local research to choose a safer review path
Direct answer
@bigtwig_1's peptide therapy claims need serious scrutiny is best used to compare access, oversight, pricing, pharmacy quality, and patient support before starting care.
Evidence check
Directory pages should connect local intent with provider standards, pharmacy transparency, and practical next steps.
Safety check
Provider quality, pharmacy source, prescribing model, and follow-up support can matter as much as the medication name.
Next step
When you are ready, the get-started flow can collect the details needed for a prescription review instead of leaving you to guess.
Helpful context before the funnel
Page-specific review note
What this exact clip is really saying
This FormBlends review is specific to "@bigtwig_1's peptide therapy claims need serious scrutiny" from BigTwig. We read the clip as a Peptide social video fact-checks claim about Peptide social video fact-checks, then separate the useful signal from what a short social video cannot prove. The page-specific claim focus is: BPC-157 and TB-500 are research peptides with preclinical data supporting healing and anti-inflammatory mechanisms, but neither has completed peer-reviewed human clinical trials establishing safety or efficacy for the indications described in this video.
The reason this review is not generic is the source wording and the canonical claim label "peptides tiktok 7449074798954695978." In this clip, the useful excerpt is: "Hey guys, I get a lot of questions about BPC and TB-500." That wording changes the review because it points to Peptide social video fact-checks evidence, safety, and patient-fit context, not a one-size-fits-all protocol.
The source trail for this page is checked against Multifunctionality and Possible Medical Application of the BPC 157 Peptide (2025), Gastric pentadecapeptide BPC 157 and its role in accelerating musculoskeletal soft tissue healing (2019), and Emerging Use of BPC-157 in Orthopaedic Sports Medicine: A Systematic Review (2025), plus the creator's own wording. Peptide social video fact-checks decisions still need an eligibility review, medication-interaction screen, access check, and quality-control review before anyone treats a social clip as medical advice.
Claim verdict
The useful answer behind this video
This page is built to answer the specific claim behind the clip, then separate what is useful from what still needs clinical context. That makes the URL more than a repost: it gives Google, readers, and AI retrieval systems a concise verdict with source and safety boundaries.
Claim being checked
BPC-157 and TB-500 are research peptides with preclinical data supporting healing and anti-inflammatory mechanisms, but neither has completed peer-reviewed human clinical trials establishing safety or efficacy for the indications described in this video.
FormBlends verdict
Peptide social video fact-checks evidence, safety, and patient-fit context
Evidence strength
Source-backed review with clinical or regulatory citations.
Patient-safe next step
Compare the claim with FormBlends safety guidance and a licensed-provider review before acting.
What to do with this video
Use the clip as a claim to verify, not a treatment plan
What it helps with
- BPC-157 and TB-500 are research peptides with preclinical data supporting healing and anti-inflammatory mechanisms, but neither has completed peer-reviewed human clinical trials establishing safety or efficacy for the indications described in this video. The creator provides a specific dosing protocol (250-500 mcg of each peptide daily or every other day) and sourcing guidance to a commercial SARMs vendor, neither of which is supported by clinical evidence or compliant with FDA regulations governing human peptide use. Any consideration of these compounds should occur under supervision of a licensed clinician with access to pharmacy-grade compounded preparations.
- BPC-157 has preclinical animal data supporting tendon and GI healing via nitric oxide pathways, but zero completed peer-reviewed human RCTs confirm these effects in people (Sikiric et al., 2018, Current Pharmaceutical Design).
- TB-500 research in humans is even thinner than BPC-157. Most published data comes from animal wound-healing models and in vitro studies (Goldstein et al., 2012, Annals of the New York Academy of Sciences).
What it may miss
- It may not cover eligibility, contraindications, medication interactions, lab history, or dose escalation.
- Compound access, legal status, and product quality still need a separate safety check.
- Social video captions rarely show the full evidence base behind a claim.
Best next step
Compare the claim against a FormBlends guide, safety page, and licensed-provider review before acting.
Start provider reviewWhat You'll Learn
- BPC-157 has preclinical animal data supporting tendon and GI healing via nitric oxide pathways, but zero completed peer-reviewed human RCTs confirm these effects in people (Sikiric et al., 2018, Current Pharmaceutical Design).
- TB-500 research in humans is even thinner than BPC-157. Most published data comes from animal wound-healing models and in vitro studies (Goldstein et al., 2012, Annals of the New York Academy of Sciences).
- A 2023 JAMA Internal Medicine analysis found that peptide and research compound products sold through unregulated online vendors frequently contain incorrect concentrations or unlisted contaminants. Vendor sourcing is not a minor detail.
- BPC-157 and TB-500 are not FDA-approved drugs for human use. Legal access in the US requires a prescription filled at an FDA-registered compounding pharmacy.
- The reconstitution technique shown, including slow rolling, wall-directed water injection, and fresh needles for each draw, is consistent with standard sterile preparation practice and represents the video's strongest content.
- No published study has tested a BPC-157 plus TB-500 combination protocol in humans. Claims about synergistic benefits are based on practitioner anecdote, not controlled evidence.
- Reconstituted peptide vials have a limited refrigerated shelf life, typically around 30 days depending on the compound. The video does not mention this, which is a relevant omission for safety.
Our take · Written by FormBlends editorial team · Reviewed by FormBlends Medical Team· This is not a transcript. It is our independent review of the video above.
What did @bigtwig_1 actually say?
The creator walked 202,000+ viewers through reconstituting a combination BPC-157 and TB-500 vial, covering bacteriostatic water prep, injection technique, dosing math, and storage. They recommend "250 micrograms of each compound daily or 500 micrograms of each compound every other day" and suggest the two peptides work better together for "healing, inflammation control, pain control." They also plug explicitsarms.com as a sourcing destination.
This is not a casual wellness video. It is a step-by-step injection tutorial directed at a general audience, with specific dosing numbers, sourcing recommendations, and medical-adjacent claims about what these compounds do in the body. That context matters when evaluating what they got right and what could genuinely hurt someone.
Does the science back this up?
The honest answer is: partially, and mostly in animal models. BPC-157 has real preclinical data behind it. TB-500 has somewhat less. The combination claim is essentially unsubstantiated in human trials.
BPC-157 (Body Protection Compound-157) is a synthetic pentadecapeptide derived from a protein found in gastric juice. Rodent studies have shown it promotes tendon, ligament, and gastrointestinal healing through nitric oxide pathways and growth factor upregulation (Sikiric et al., 2018, Current Pharmaceutical Design). That is legitimate science. The problem is that no peer-reviewed, controlled human clinical trial has confirmed these effects in people. TB-500, a synthetic version of the naturally occurring Thymosin Beta-4, has shown wound-healing and anti-inflammatory properties in animal and some small in vitro studies (Goldstein et al., 2012, Annals of the New York Academy of Sciences), but again, human trial data is sparse. The creator's claim that pairing them produces "significant results" is anecdotal, not evidence-based, and the "tremendous benefits" framing overstates what the literature actually supports.
What did they get wrong (or right)?
Credit where it is due: the reconstitution technique is largely sound. Injecting water against the glass wall rather than directly onto the lyophilized powder is correct practice for protecting fragile peptide bonds. Recommending slow rolling instead of shaking is accurate. Using a fresh needle before drawing from a stored vial, and swabbing the septum, reflects legitimate sterile technique.
Where things go sideways is sourcing. Directing viewers to explicitsarms.com is a significant red flag. Compounds sold through research chemical or SARMs-adjacent vendors are not subject to FDA manufacturing oversight. A 2023 analysis by Piber et al. (JAMA Internal Medicine) found that peptide products from unregulated online vendors frequently contain incorrect concentrations or unlisted contaminants. The creator also skips over the legal status entirely: BPC-157 and TB-500 are not FDA-approved drugs. They are not legal to sell for human use in the United States outside of a licensed compounding pharmacy operating under a valid prescription. Pointing a mass audience to a commercial SARMs site without that disclaimer is irresponsible.
The dosing math presented is internally consistent, but presenting specific microgram doses to a general audience as if they are safe defaults ignores individual variation in body weight, health status, and the complete absence of established safe dosing ranges from human trials.
What should you actually know?
If you are genuinely interested in peptide therapy, the biology is interesting enough to take seriously without the shortcuts. Here is what the evidence actually supports, and what it does not.
- BPC-157 has the stronger preclinical dataset of the two. Multiple rodent studies show accelerated tendon and GI healing. Human data does not yet confirm this translates directly.
- TB-500 has biological plausibility via Thymosin Beta-4 mechanisms, but even fewer human studies exist than for BPC-157.
- The idea that combining them is synergistic is a popular gym-culture belief, not a documented pharmacological finding.
- Sourcing from unregulated vendors introduces real risk: contamination, incorrect dosing concentration, and unknown impurities. This is not a hypothetical concern.
- Reconstituted peptide vials stored in a refrigerator are generally considered stable for roughly 30 days, though this varies by compound and reconstitution conditions. The creator does not mention this window.
- If you want to explore peptide therapy legally and safely, a licensed telehealth provider operating through an FDA-registered compounding pharmacy is the appropriate route. Full stop.
Interested in GLP-1 or peptide therapy?
Get matched with licensed-provider review to help decide if it is right for you.
About the Creator
BigTwig · TikTok creator
202.6K views on this video
@bigtwig_1's peptide therapy claims need serious scrutiny
Frequently asked questions
Quick answers based on this video and our medical team review.
What does the video say about bpc-157 has preclinical animal data supporting tendon?
BPC-157 has preclinical animal data supporting tendon and GI healing via nitric oxide pathways, but zero completed peer-reviewed human RCTs confirm these effects in people (Sikiric et al., 2018, Current Pharmaceutical Design).
What does the video say about tb-500 research in humans?
TB-500 research in humans is even thinner than BPC-157. Most published data comes from animal wound-healing models and in vitro studies (Goldstein et al., 2012, Annals of the New York Academy of Sciences).
What does the video say about a 2023 jama internal medicine analysis found?
A 2023 JAMA Internal Medicine analysis found that peptide and research compound products sold through unregulated online vendors frequently contain incorrect concentrations or unlisted contaminants. Vendor sourcing is not a minor detail.
What does the video say about bpc-157?
BPC-157 and TB-500 are not FDA-approved drugs for human use. Legal access in the US requires a prescription filled at an FDA-registered compounding pharmacy.
What does the video say about the reconstitution technique shown, including slow rolling, wall-directed water injection,?
The reconstitution technique shown, including slow rolling, wall-directed water injection, and fresh needles for each draw, is consistent with standard sterile preparation practice and represents the video's strongest content.
What does the video say about no published study has tested a bpc-157 plus tb-500 combination?
No published study has tested a BPC-157 plus TB-500 combination protocol in humans. Claims about synergistic benefits are based on practitioner anecdote, not controlled evidence.
Sources & references
Citations extracted from our medical team's review. Click any citation to search PubMed.
Read More on This Topic
Our written guides go deeper with dosing details, comparison tables, and medical-team reviewed protocols.
Not medical advice. This video was made by BigTwig, not by FormBlends. Our write-up above is an editorial review, not a medical recommendation. Talk to your doctor before making any decisions about medications or treatments.